Logotype for Cannara Biotech Inc

Cannara Biotech (LOVE) investor relations material

Cannara Biotech Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Cannara Biotech Inc
Q4 2025 earnings summary24 Nov, 2025

Executive summary

  • Fiscal 2025 achieved record highs in net revenue ($107.3 million), adjusted EBITDA ($28.1 million), net income ($13.1 million), and positive retained earnings, driven by capacity expansion and operational efficiency.

  • National market share rose to 3.81%, up 32% year-over-year, with Quebec market share increasing over 53% to 12.72%.

  • Cultivation capacity increased nearly 50% year-over-year, reaching the fiscal 2026 target a year early by activating two additional grow zones, totaling 12 and annual output of 50,000 kg.

  • The company remains focused on disciplined, efficient operations, quality products, and leveraging proprietary technology, including AI for cultivation optimization.

  • Launched new products and entered Quebec's vape cartridge category with 20% of accepted SKUs.

Financial highlights

  • Net revenue for the year was CAD 107.3 million, up 31% year-over-year, with gross revenue just under CAD 149 million.

  • Gross profit before fair value adjustments reached CAD 44.5 million (41% margin), up from 34% last year.

  • Adjusted EBITDA was CAD 28.1 million (26% margin), up from 18% last year; net income doubled to CAD 13.1 million.

  • Q4 revenue hit a record CAD 28.3 million, up 3.5% sequentially and 21% year-over-year; Q4 adjusted EBITDA rose 102% to CAD 7.5 million.

  • Free cash flow for FY25 was CAD 13.7 million, up from CAD 3.2 million in FY24; operating cash flow for the year was CAD 20 million.

Outlook and guidance

  • Management expects continued margin improvement as new rooms and post-processing capacity come online, targeting gross margins above 40% and potentially up to 50%.

  • Plans to operationalize 12 additional grow rooms at Valleyfield, potentially doubling cultivation capacity over four years.

  • Fiscal 2026 capital investment strategy prioritizes a new processing center, funded by a $10 million BMO term loan.

  • Steady, annual growth is anticipated, with no plans for rapid spikes or declines.

  • Focus on successful execution of the November vape category launch in Quebec and post-processing expansion at Valleyfield.

Quebec vape launch: initial performance
Valleyfield capacity expansion timeline
What drove market share gains in smaller provinces?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Cannara Biotech earnings date

Logotype for Cannara Biotech Inc
Q1 202626 Jan, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Cannara Biotech earnings date

Logotype for Cannara Biotech Inc
Q1 202626 Jan, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Cannara Biotech Inc. is a Canadian vertically integrated producer of premium-grade cannabis and cannabis-derivative products targeted at the Quebec and Canadian markets. The company is known for its large-scale operations, owning two mega facilities based in Quebec. The company's business model focuses on leveraging its extensive cultivation and processing capabilities to provide a wide range of cannabis products. Cannara Biotech operates in two main segments: Cannabis operations and Real estate operations. The company is headquartered in Saint-Laurent, Canada, and its shares are listed on the TSX.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage